Chu Myron - R&D Immunoinflammat, GlaxoSmithKline

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Escalation Study to Evaluate the Safety and Pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C Chemokine Receptor Type 5 Directed Antibody, in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis

Stanley Cohen,Jean S. Beebe,Vishala Chindalore,Shunjie Guan,Mina Hassan-Zahraee, Madhurima Saxena,Li Xi,Craig Hyde, Sarita Koride,Robert Levin,Shannon Lubaczewski,Mikhail Salganik,Abigail Sloan,Erin Stevens,Elena Peeva,Michael S. Vincent,David A. Martin,Myron Chu

Arthritis Research & Therapy（2024）

引用0浏览0WOS引用

Ab0511 a phase 1, randomised, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety, pharmacokinetics and pharmacodynamics of pf-06835375 in patients with seropositive systemic lupus erythematosus or rheumatoid arthritis

Sacha Baron Cohen,Jean S. Beebe,Vishala Chindalore, Sheng-Uei Guan,Mina Hassan‐Zahraee,Craig Hyde, S. Koride,Robert D. Levin,Shannon Lubaczewski, M.P. Salganik, A. Sloan,Erin Stevens,Elena Peeva,Michael S. Vincent,David Martin,Myron Chu

Annals of the Rheumatic Diseasesno. Suppl 1 (2023): 1450.2-1450

引用0浏览0引用

Pos1207 efficacy and safety of anti-ifnβ-specific monoclonal antibody, pf-06823859, on myositis: phase 2 study in patients with moderate-to-severe dermatomyositis

R. Aggarwal, Izabela Domysławska, Patrícia Carreira,David Fiorentino,Jason C. Sluzevich,Victoria P. Werth,Anindita Banerjee,Myron Chu, Barry S. Oemar, M.P. Salganik, A. Sloan,Michael S. Vincent,Elena Peeva

Annals of the Rheumatic Diseasesno. Suppl 1 (2023): 936.1-937

引用0浏览0引用

Rapid Onset of Response in Adult Dermatomyositis Patients Receiving Anti-interferon Β (PF-06823859): Results of a Phase 2, Double-blind, Randomized, Placebo-Controlled Study

Rohit Aggarwal,Elena Peeva, Aaron Mangold, Abigail Sloan,Myron Chu

ARTHRITIS & RHEUMATOLOGY (2023): 5127-5129

引用0浏览0引用

Efficacy of Belimumab in Patients with Systemic Lupus Erythematosus from North East Asia: Results of Exploratory Subgroup Analyses

Jie Zheng,Jieruo Gu,Yin Su,Yang Li,Xingfu Li,Cui Xiong,Hua Cao,Holly Quasny,Myron Chu,Paula Curtis,Kathleen DeRose,Regina Kurrasch,Paige Meizlik,David A. Roth,Fengchun Zhang

Modern Rheumatologyno. 4 (2022): 751-757

引用2浏览0WOS引用

Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years

Fengchun Zhang,Jie Zheng,Yang Li,Guochun Wang,Mingjun Wang,Yin Su,Jieruo Gu,Xingfu Li,Damon Bass,Myron Chu,Paula Curtis,Kathleen DeRose,Regina Kurrasch,Jenny Lowe,Paige Meizlik,David A Roth

RMD OPEN（2022）

引用4浏览0WOS引用

The Effect of 24-Week Belimumab Treatment Withdrawal Followed by Treatment Restart in Patients with SLE: an Open-Label, Non-Randomised 52-Week Study

Bae Sang-Cheol,Bass Damon L.,Chu Myron,Curtis Paula,Dimelow Richard, Harvey Laurence,Ji Beulah,Kurrasch Regina, Muzaffar Saima,Punwaney Raj,Roth David A.,Song Yeong-Wook,Xie Wendy,Zhang Fengchun

Arthritis research & therapy（2022）

引用4浏览0WOS引用

Long-term Open-Label Continuation Study of the Safety and Efficacy of Belimumab for Up to 7 Years in Patients with Systemic Lupus Erythematosus from Japan and South Korea

Yoshiya Tanaka,Sang-Cheol Bae,Damon Bass,Paula Curtis,Myron Chu,Kathleen DeRose,Beulah Ji,Regina Kurrasch,Jenny Lowe,Paige Meizlik,David A. Roth

RMD Open（2021）

引用17浏览0引用

Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: a subgroup analysis from a Phase 3 randomized placebo-controlled trial

Yoshiya Tanaka,Damon Bass,Myron Chu,Sally Egginton,Beulah Ji,David Roth

MODERN RHEUMATOLOGY（2020）

引用12浏览0WOS引用

A PHASE 3, OPEN-LABEL, CONTINUATION STUDY EVALUATING LONG-TERM SAFETY AND EFFICACY OF BELIMUMAB IN PATIENTS FROM JAPAN AND KOREA WITH SYSTEMIC LUPUS ERYTHEMATOSUS, FOR UP TO 7 YEARS

Y. Tanaka,S. C. Bae,D. Bass,M. Chu,P. Curtis, K. Derose,B. Ji,R. Kurrasch, J. Lowe,P. Meizlik,D. Roth

ANNALS OF THE RHEUMATIC DISEASES（2020）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn